Clinical trial Recruiting at 3 sites Interventional Ages 18 and up Men only

Physical activity program to reduce cancer-related fatigue in men with metastatic testicular cancer

Official title: A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients

Run by Centre Leon Berard · NCT05588700 · Data updated 2026-11-12

This study is testing whether a physical activity program can help men with metastatic testicular cancer feel less tired and improve their overall quality of life.

More Metastatic Testicular Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment236 (estimated)
SponsorCentre Leon Berard
Academic / other
Drugs / interventionschemotherapy
Locations12 sites (Angers and 11 other locations)
StatusRecruiting
StartedJanuary 14, 2025
Main results expectedJanuary 14, 2031
Study endsJanuary 14, 2038
Registry record updatedMarch 31, 2026
Trial IDNCT05588700 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men aged 18 and older with a confirmed diagnosis of metastatic germ cell tumor who have undergone orchidectomy and are scheduled for first-line chemotherapy.

Probably not a fit

Patients with symptomatic bone or brain metastases or those with neurological deficits preventing physical activity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a physical activity program on reducing long-term cancer-related fatigue in men diagnosed with metastatic testicular germ cell tumors. Participants will engage in a structured physical activity intervention, monitored through connected activity trackers, to assess improvements in fatigue and overall quality of life. The study also aims to explore the relationship between physical activity, gut microbiota composition, and the sequelae experienced by cancer survivors. By focusing on this specific patient population, the study seeks to fill a gap in existing research regarding the benefits of physical activity for testicular cancer survivors.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and reduce fatigue for patients recovering from metastatic testicular cancer.

How similar studies have gone: While there is growing evidence supporting the benefits of physical activity in cancer patients, this specific approach focusing on testicular cancer survivors is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men ≥18 years
* With a metastatic germ cell tumor histologically confirmed (seminoma and non-seminoma)
* Who have already undergone an orchidectomy (since the 16th december, this criteria was deleted).
* Having a first line of chemotherapy planned with BEP, EP or VIP
* Having a smartphone (i.e. to connect the activity tracker)
* PS \< or = 2
* Whose ability to practice an adapted physical activity (APA) has been certified by a medical certificate issued by the referring oncologist or the investigating physician
* Available and willing to participate in the study for the duration of the intervention and follow-up,
* Able to understand, read and write French,
* Affiliated with a social security scheme,
* Having dated and signed an informed consent.

Exclusion Criteria:

* Presence of symptomatic bone and/or brain metastases
* Central nervous system involvement with neurological deficits preventing walking
* History or coexistence of another primary cancer (apart from in situ cancer of any location and/or basal cell skin cancer and/or basal cell skin cancer and/or a cancer in complete remission for more than 3 years),
* Contraindication to physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease) uncontrolled heart disease),
* Unable to be followed for medical, social, family, geographical or psychological reasons, during the entire study period,
* Deprived of liberty by judicial or administrative decision, or adults protected by law,
* Concurrent participation in another study in PA.

Where it's running

  • Centre Leon Berard
    Lyon, France
    Recruiting
  • Institut de Cancérologie de Lorraine
    Nancy, France
    Recruiting
  • Institut Gustave Roussy
    Villejuif, France
    Recruiting
  • Institut de Cancérologie de Lorraine
    Angers, France
    Not yet recruiting
  • CHU Jean Minjoz
    Besançon, France
    Not yet recruiting
  • Institut Bergonié
    Bordeaux, France
    Not yet recruiting
Show 6 more locations
  • Centre François Baclesse
    Caen, France
    Not yet recruiting
  • Centre Oscar Lambret
    Lille, France
    Not yet recruiting
  • Centre Antoine Lacassagne
    Nice, France
    Not yet recruiting
  • AP-HP Tenon
    Paris, France
    Not yet recruiting
  • Centre Eugène Marquis
    Rennes, France
    Not yet recruiting
  • CHU Tours
    Tours, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.